Home » Topics » Disease categories and therapies » Infection

Infection
RSS

1999 AAPS: Agouron presents nasal disposition studies with AG-7088

Nov. 25, 1999

IDSA highlights: IntraBiotics presents results of successful ramoplanin phase II trial

Nov. 25, 1999

Topical antifungal agents with in vitro and in vivo efficacy developed at Hanwha

Nov. 24, 1999

Microcide's novel cephalosporin antibiotic enters the clinic

Nov. 24, 1999

Solid-phase synthesis and use of novel inhibitors of aspartyl proteases reported by Pharmacopeia

Nov. 23, 1999

New data presented on Pentose's product for viral inactivation of blood components

Nov. 22, 1999

SSP and Nippon Kayaku codevelop antifungal triazole

Nov. 19, 1999

News from AASP: preclinical PK data for PNU-179954 support further development

Nov. 19, 1999

New anti-HCMV compound from BioChem Pharma shows favorable PK profile in mice

Nov. 19, 1999

Neuraminidase inhibitors a focus of investigation at Abbott

Nov. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....